US Patent 7524825 Tricyclic-nucleoside compounds for treating viral infections
Patent 7524825 was granted and assigned to Smithkline Beecham Limited on April, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Jesse Daniel Keicher0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+188 characters)
Article
Patent abstract
Disclosed are compounds represented by formulae I, II, and III, and the compositions and methods thereof for treating viral infections caused by a Flaviviridae family virus.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07524825 Tricyclic-nucleoside compounds for treating viral infections US Patent 7524825 Tricyclic-nucleoside compounds for treating viral infections
Infobox
Patent Number
07524825
Patent Number
7524825
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07524825 Tricyclic-nucleoside compounds for treating viral infections
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07524825
Date of patent
April 28, 2009
Patent application number
11365321
Date Filed
February 28, 2006
Patent primary examiner
Find more entities like US Patent 7524825 Tricyclic-nucleoside compounds for treating viral infections
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
